Impact of payment source, referral site, and place of residence on outcomes after allogeneic transplantation in Mexico

Table 1 Baseline characteristics of 287 patients who received an allogeneic hematopoietic cell transplant

Variable		n	%
Sex	Male	168	58.6
	Female	119	41.5
Age	Median (years)	35	(16-79)
Country of origin	Mexico	270	94
	Other	17	6
State of origin	Nuevo Leon	123	42.9
	Other	164	57.1
Institution	Referral	165	57.5
	Local	122	42.5
Diagnosis	AML	77	26.8
	ALL	76	26.4
	AA	36	12.5
	NHL	29	10.1
	MDN	25	8.7
	HL	17	5.9
	CML	10	3.4
	CMML	6	2.1
	PMF	4	1.4
	CLL	4	1.4
	MM	3	1
Donor	Matched sibling	111	38.7
	Haploidentical	176	61.3
DRI	Non-malignant	36	12.6
	Intermediate	117	40.8
	High	100	34.8
	Very high	27	9.4
HCT-CI	Median	0	(0-5)
Treatment lines	Median	2	(0-6)
Payment source	Out-of-pocket	139	48.4
	Private insurance	75	26.1
	Universal coverage	73	25.4

DRI: Disease risk index; HCT-CI: Hematopoietic cell comorbidity index; AML: Acute myeloid leukemia; AA: Aplastic anemia; NHL: Non Hodgkin lymphoma; MDN: Myeldysplastic neoplasm; HL: Hodgkin lymphoma; CML: Chronic myeloid leukemia; CMML: Chronic myelomonocytic leukemia; MF: Myelofibrosis; CLL: Chronic lymphocytic leukemia; MM: Multiple myeloma.